| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |